发明名称 THERAPEUTIC COMPOUNDS
摘要 The invention provides compounds of formula (I):;;wherein, A, C, D, X, and Y have any of the values defined in the specification, and salts thereof. The compounds are SIRT2 inhibitors and are useful for treating SIRT2 associated conditions.
申请公布号 US2016376238(A1) 申请公布日期 2016.12.29
申请号 US201615192728 申请日期 2016.06.24
申请人 REGENTS OF THE UNIVERSITY OF MINNESOTA 发明人 Chen Liqiang;Ai Teng;More Swati
分类号 C07D213/82;C07D405/12;C07D401/12;C07B59/00;C07D409/14;C07D405/14;C07D401/14;C07D413/12;C07D409/12;C07D417/12 主分类号 C07D213/82
代理机构 代理人
主权项 1. A compound of formula (I):wherein: X is CH or N; Y is CH or N; A is selected from the group consisting of: -A′-B′—, A′ is selected from the group consisting of: B′ is phenyl, a 5-membered heteroaryl, or a 6-membered heteroaryl, wherein A′ and C are attached to B′ in a meta-orientation, and the phenyl, 5-membered heteroaryl, and 6-membered heteroaryl are optionally substituted with one or more groups independently selected from F, Cl, deuterium, methyl, trifluoromethyl, methoxy, and trifluoromethoxy; C is selected from the group consisting of: D is selected from the group consisting of (C1-C6)alkyl, (C2-C6)alkenyl, (C3-C15)carbocycle, aryl, and heteroaryl, wherein the (C1-C6)alkyl, (C2-C6)alkenyl, (C3-C15)carbocycle, aryl, and heteroaryl, are optionally substituted with one or more groups Rz independently selected from halo, deuterium, nitro, hydroxy, cyano, carboxy, —NRaRb, —C(═O)NRaRb, —N—S(O)2Ra, —NRaC(═O)NRaRb, (C1-C4)alkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, (C1-C4)alkoxy, (C1-C4)alkanoyl, (C1-C4)alkoxycarbonyl, (C1-C4)alkanoyloxy, (C3-C15)carbocycle, aryl, aryloxy, and heteroaryl, wherein any (C1-C4)alkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, (C1-C4)alkoxy, (C1-C4)alkanoyl, (C1-C4)alkoxycarbonyl, (C3-C15)carbocycle, and (C1-C4)alkanoyloxy of Rz is optionally substituted with one or more groups independently selected from the group consisting of halo, hydroxy, deuterium, —NRaRb, (C1-C4)alkoxy, (C1-C4)alkoxycarbonyl, (C1-C4)alkanoyloxy, aryl, aryloxy, and heteroaryl, wherein any aryl, aryloxy, and heteroaryl of Rz is optionally substituted with one or more groups independently selected from the group consisting of halo, deuterium, halo, nitro, cyano, hydroxy, —NRaRb, (C1-C4)alkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, (C1-C4)alkoxy, (C1-C4)alkoxycarbonyl, (C1-C4)alkanoyloxy, (C1-C4)haloalkyl, Rx, and (C1-C4)haloalkoxy; each Ra and Rb is independently selected from the group consisting of H, (C1-C4)alkyl, (C3-C8)cycloalkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, (C1-C4)alkoxy, (C1-C4)alkanoyl, (C1-C4)alkoxycarbonyl, (C1-C4)alkanoyloxy, aryl, and heteroaryl, wherein any (C1-C4)alkyl, (C3-C8)cycloalkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, (C1-C4)alkoxy, (C1-C4)alkanoyl, (C1-C4)alkoxycarbonyl, and (C1-C4)alkanoyloxy is optionally substituted with one or more groups independently selected from the group consisting of halo, deuterium, hydroxy, (C3-C15)carbocycle, (C1-C4)alkoxy, (C1-C4)alkoxycarbonyl, (C1-C4)alkanoyloxy, oxo (═O), aryl, and heteroaryl, and wherein any aryl and heteroaryl is optionally substituted with one or more groups independently selected from the group consisting of halo, deuterium, nitro, cyano, carboxy, (C1-C4)alkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, (C3-C15)carbocycle, —NRcRd, —C(═O)NRcRd, (C1-C4)alkoxycarbonyl, (C1-C4)haloalkyl, aryl, heteroaryl, and ReO—; or Ra and Rb together with the nitrogen to which they are attached form an azetidinyl, morpholino, piperazino, pyrrolidino or piperidino, wherein any a azetidinyl, morpholino, piperazino, pyrrolidino, 1,1-(dioxido)thiomorpholino and piperidino is optionally substituted with one or more groups independently selected from halo, oxo, and (C1-C4)alkyl; each Rc and Rd is independently selected from the group consisting of H, (C1-C4)alkyl, (C3-C8)cycloalkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, and (C1-C4)alkoxy, wherein any (C1-C4)alkyl, (C3-C8)cycloalkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, (C1-C4)alkoxy, (C1-C4)alkanoyl, (C1-C4)alkoxycarbonyl, and (C1-C4)alkanoyloxy is optionally substituted with one or more groups independently selected from the group consisting of halo, hydroxy, deuterium, (C3-C15)carbocycle, (C1-C4)alkoxy, (C1-C4)alkoxycarbonyl, (C1-C4)alkanoyloxy, and oxo (═O); or Rc and Rd together with the nitrogen to which they are attached form a morpholino, piperazino, pyrrolidino or piperidino; Re is selected from the group consisting of H, (C1-C4)alkyl, (C3-C8)cycloalkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, aryl, and (C1-C4)alkanoyl, wherein any (C1-C4)alkyl, (C3-C8)cycloalkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, and (C1-C4)alkanoyl is optionally substituted with one or more groups independently selected from halo and aryl, and wherein any aryl is optionally substituted with one or more groups independently selected from halo deuterium, nitro, cyano, hydroxy, carboxy, (C1-C4)alkyl, (C1-C4)alkoxy, (C1-C4)alkoxycarbonyl, and (C1-C4)alkanoyloxy; and each Rx is (C1-C4)alkyl that is substituted with one or more (e.g. 1, 2, 3, or 4) groups independently selected from oxo, carboxy, (C1-C4)alkoxycarbonyl, and amino; or a salt thereof.
地址 Minneapolis MN US